Abbott Laboratories posted its largest-ever quarter for rapid diagnostics, according to a news release from data analytics and consulting firm GlobalData. The company’s rapid diagnostics segment sold ...
Abbott Laboratories saw its shares down 10% at the end of trading Thursday, Jan. 22, as the market digested weaknesses from its fourth-quarter and full-year earnings report. | Abbott Laboratories saw ...
ABBOTT PARK, Ill., March 31, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has received U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for over-the-counter, non ...
Abbott’s Alinity m Resp-4-Plex molecular assay, which was designed to test for four viruses in one test, has been authorized for emergency use by the US Food and Drug Administration (FDA). Shares of ...
ABBOTT PARK, Ill., June 17, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that its Afinion™ HbA1c Dx assay is now available for use on the Afinion 2 Analyzer, as well as the Afinion AS100 ...
Feb 1 (Reuters) - Abbott Laboratories said it would buy Alere Inc for $5.8 billion and become the leader in point-of-care diagnostic testing, a market that is growing as physicians increasingly adopt ...
INDIANAPOLIS, (WISH) – The holidays are about spreading joy, but it’s also a time when celebrating with friends and family can get us sick. On Tuesday, Dr. Mary Rodgers, a Ph.D. who is an Abbott ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results